Clinical Trials

Lazaro Barajas’ cancer had developed resistance to standard chemotherapy and immunotherapy

By uclahealth • December 27, 2022

Lazaro Barajas will be honored as a Laker For A Day, for his courage and determination

By uclahealth • November 2, 2022

‘We have a very large clinical trial profile which allows us to have access to novel therapies and new treatment strategies,’ says Dr. Ritu Salani

By uclahealth • October 10, 2022

VALOR trial aims to discover the optimal treatment for stage 1 lung cancer

By Sandy Cohen • May 9, 2022

A UCLA HemOnc Fellow is determined to reduce cancer disparities

By Jocelyn Apodaca Schlossberg • April 25, 2022

The first participant in the trial not only decreased his daily insulin use by 91%, but for the first time in his life, his body is producing insulin in response to blood sugar fluctuation

By Ask the Doctors • January 7, 2022

What makes this parasomnia so frightening?

By Chayil Champion • October 15, 2021

Groundbreaking science and cross-specialty collaboration enable transplant recipients to thrive without immunosuppressive drugs

By Sandy Cohen • August 4, 2021

‘It is a recognition of the scholarly environment and infrastructure we have built to enable and foster outstanding scientific research,’ says David Geffen School of Medicine Dean Kelsey Martin

By Sandy Cohen • March 22, 2021

Laurie Adami participated in the trial for the immunotherapy treatment, which received FDA approval March 5

By uclahealth • March 5, 2021